Insider tradingForm 4

AbCellera Biologics Inc. (ABCL) Insider Trading

4 open-market trades reported since Aug 14, 2026: 4 purchases worth $1.55M and 0 sales worth $0.

By insider

Insider	Role	Buys	Bought	Sold	Latest
Michael R. Hayden	Director	2	$1.05M	$0	Aug 24, 2026
John S. Montalbano	Director	1	$110K	$0	Aug 18, 2026
Andrew Booth	CFO	1	$384K	$0	Aug 14, 2026

ABCL insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Aug 24	Aug 24	Michael R. HaydenDirector	Director (ind.)	▲ BUY	53,613	10.64	$570K	+4.1%	Form 4 ↗
Aug 18	Aug 18	John S. MontalbanoDirector	Director	▲ BUY	10,000	11.03	$110K	+4.1%	Form 4 ↗
Aug 14	Aug 12	Michael R. HaydenDirector	Director (ind.)	▲ BUY	46,387	10.37	$481K	+3.6%	Form 4 ↗
Aug 14	Aug 14	Andrew BoothCFO	CFO	▲ BUY	37,200	10.32	$384K	+8.3%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings